There are 2949 resources available
Panel discussion
Presenter: George Demetri, Jorge Camarero, Oriol Solà-Morales, Renate Haidinger
Session: Pfizer Oncology - RWE and me: Multidisciplinary views on real-world evidence (RWE) in oncology
Resources:
Webcast
Welcome and Introduction
Presenter: James Larkin
Session: Bristol Myers Squibb - Harnessing the Potential of the Immune System: Clinical Insights From Utilizing CTLA-4 Within a Dual I-O Approach in aRCC
Resources:
Webcast
Deepening Our Understanding of Dual Checkpoint Inhibition
Presenter: Michael Atkins
Session: Bristol Myers Squibb - Harnessing the Potential of the Immune System: Clinical Insights From Utilizing CTLA-4 Within a Dual I-O Approach in aRCC
Resources:
Webcast
Welcome and introduction
Presenter: Tanja Cufer
Session: Boehringer Ingelheim - Focus on NSCLC treatment options
Resources:
Webcast
Treatments After Progression in the First-Line of Non-Mutated NSCLC Adenocarcinoma
Presenter: Silvia Novello
Session: Boehringer Ingelheim - Focus on NSCLC treatment options
Resources:
Webcast
Uncommon EGFR mutations
Presenter: Xiuning Le
Session: Boehringer Ingelheim - Focus on NSCLC treatment options
Resources:
Webcast
The Future of NSCLC
Presenter: Melissa Johnson
Session: Boehringer Ingelheim - Focus on NSCLC treatment options
Resources:
Webcast
Key insights and closing remarks
Presenter: Tanja Cufer
Session: Boehringer Ingelheim - Focus on NSCLC treatment options
Resources:
Webcast
Challenges in the treatment of prostate cancer
Presenter: Daniel George
Session: Pfizer Oncology - Building a new paradigm in prostate cancer
Resources:
Webcast
Maximizing outcome with NHTs
Presenter: Arnulf Stenzl
Session: Pfizer Oncology - Building a new paradigm in prostate cancer
Resources:
Webcast